Erythroblasts possess unique characteristics as they undergo differentiation from hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large amounts of iron in order to ...

The detectability of erythropoiesis stimulating agent abuse is a major challenge on the way to a doping free sport. Despite existing tests, the detection of ESA abuse has proven to be very difficult.

Haemostasis is the prevention of unwanted blood loss; lean how this process works and is interrupted by blood-clotting and ...

Therefore, the researchers suggest discontinuing daprodustat to reduce the risk of recurrent ischemic strokes. Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors are ...

With a market cap of $2.67 billion, Geron Corporation (GERN) is a small-cap, commercial-stage biopharmaceutical company ...

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence ...

Among patients with myelodysplastic syndromes (MDS), treatment with Reblozyl (luspatercept) resulted in at least 12 weeks of ...

Erythropoietin (EPO), expressed in red blood progenitor cells, primarily regulates erythropoiesis by binding to its receptor. Besides anemia, recent studies have identified new therapeutic indications ...

Agios Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Researchers have identified daily oral vadadustat as a non-inferior treatment option compared with darbepoetin alfa for the ...

The following is a summary of “Supplemental Iron and Recombinant Erythropoietin for Anemia in Infants Born Very Preterm: A ...